RxDoctor Payments Data

Michael Bergstein, MD

Facial Plastic Surgery · Tarrytown, NYNPI 1679512727

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $6,416 of the $7,999 with a category attached, or 80.2%. 34 manufacturers reported payments, led by Intersect ENT, Inc. at 24.8% of the total. Reporting peaked in 2019 at $2,587 and has fallen 67.4% since, to $844 in 2025.

$7,999in general payments, 2019–2025

Across 260 payments — averaging $30.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intersect ENT, Inc.$2K
  • Optinose US, Inc.$1K
  • GSK$1K
  • Sanofi$453
  • Aerin Medical Inc.$438
  • Pentax Of America, Inc.$355
  • plus $3K from 28 others

What the payments were for

  • Consulting fees$3554%
  • Travel & lodging$1,22815%
  • Food & beverage$6,41680%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,999 in reported general payments places this provider in the 85th percentile of 48 facial plastic surgery providers in New York.

See all facial plastic surgery providers in New York

Medicare billing

Part B allowed, 2024
$441,076
Medicare patients
1,046
Services billed
3,487

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab13$43,726
Famotidine751$10,463
Dexlansoprazole DrDexlansoprazole20$9,665
Fluticasone Propionate309$7,244
Pantoprazole Sodium458$6,966
Ipratropium Bromide286$6,224
Esomeprazole Magnesium47$1,629
Azelastine Hcl61$1,621
Omeprazole66$1,460
Mometasone Furoate79$682
Methylprednisolone109$591
Ofloxacin16$537
Cefdinir15$373
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav27$228
Doxycycline Hyclate25$177

Paid to pharmacies, not to this prescriber.

Other facial plastic surgery in Tarrytown

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →